Peptide Schedule
GHRP-66 residuesHWAWFKEach bubble = one amino acid. Size = residue mass. Color = chemical class.GHRP-6
Benefits
About GHRP-6
GHRP-6 (Growth Hormone Releasing Peptide-6) is one of the most potent GH secretagogues available. It works by mimicking ghrelin, the hunger hormone, which triggers a strong growth hormone pulse from the pituitary. Unlike Ipamorelin, GHRP-6 significantly increases appetite and raises cortisol and prolactin slightly. This makes it ideal for mass-gaining protocols where increased caloric intake is desired.
Who Should Consider GHRP-6
- Adults seeking increased GH output for muscle growth
- Hard gainers needing appetite stimulation
- Athletes in mass-gaining or bulking phases
- Individuals stacking with GHRH peptides for amplified GH release
- Adults interested in improved sleep and recovery
What to Expect
Initial GH pulses detectable within 15-30 minutes of injection. Intense hunger onset ~20 minutes post-dose. Possible tingling, dizziness, or flushing at injection site.
Appetite increase becomes predictable and pronounced. Sleep quality begins to improve, especially with evening dosing. Mild water retention may appear.
Cumulative GH elevation supports noticeable recovery improvements. Body composition shifts begin — increased lean mass, reduced fat. Hunger effects stabilize as users adapt meal timing around doses.
Full benefits realized — improved muscle fullness, faster recovery, deeper sleep. Cortisol and prolactin elevations remain mild and transient at standard doses. Consider cycling off after 8-12 weeks to prevent receptor desensitization.
Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 100mcg | Daily |
| Moderate | 200mcg | 2x Daily |
| Aggressive | 300mcg | 3x Daily |
Note: Strongest GH pulse among GHRPs. Dramatically increases appetite via ghrelin mimicry. Best for mass gaining protocols. Take on empty stomach 20-30 min before meals.
Pharmacokinetics
Source: Gonzalez et al. Eur J Pharm Sci 2013 (PMID 23099431) — distribution t½ 7.6 min, elimination t½ ~2.5 h; commonly cited plasma t½ ~20 min
Loading the interactive decay curve.
Side Effects
Intense hunger (can be a benefit or drawback). Mild cortisol and prolactin elevation. Water retention. Tingling and dizziness post-injection.
Contraindications
- Active malignancy or history of cancer (GH may promote tumor growth)
- Pregnancy or breastfeeding
- Uncontrolled diabetes or severe insulin resistance
- Active pituitary tumors or other intracranial neoplasia
- Known hypersensitivity to GHRP-6 or related peptides
- Severe obesity with untreated sleep apnea (GH may worsen)
Drug Interactions
- Insulin and sulfonylureas — GH opposes insulin action; monitor blood glucose closely for hypoglycemia risk
- Somatostatin analogs (octreotide, lanreotide) — directly antagonize GHRP-6 GH-releasing mechanism
- Corticosteroids — combined cortisol elevation may impair glucose tolerance and recovery
- Dopamine agonists (cabergoline, bromocriptine) — may blunt prolactin response but alter GH release dynamics
- Appetite suppressants (GLP-1 agonists, phentermine) — pharmacological conflict with GHRP-6 orexigenic effects
Molecular Profile
Related Peptides
References
- Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers (Eur J Pharm Sci 2013)PubMed 23099431
- Growth hormone releasing peptide (GHRP-6) stimulates phosphatidylinositol turnover in human pituitary somatotroph cells (J Mol Endocrinol 1995)PubMed 7772238
- Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects (Front Endocrinol 2017)PubMed 28458653
- Growth Hormone-Releasing Peptide 6 Enhances the Healing Process and Improves the Esthetic Outcome of the Wounds (Plast Surg Int 2016)PubMed 27200188
- Effects of GHRP-6 on the nocturnal secretion of GH, ACTH and cortisol and on the sleep EEG in man (J Neuroendocrinol 1999)PubMed 10336729